Literature DB >> 5319301

Reaction time ("mental set") in control and chronic schizophrenic subjects and in postaddicts under placebo, LSD-25, morphine, pentobarbital and amphetamine.

A Wikler, C A Haertzen, R D Chessick, H E Hill, F T Pescor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5319301     DOI: 10.1007/BF00402365

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  6 in total

1.  THE ADDICTION RESEARCH CENTER INVENTORY: STANDARDIZATION OF SCALES WHICH EVALUATE SUBJECTIVE EFFECTS OF MORPHINE, AMPHETAMINE, PENTOBARBITAL, ALCOHOL, LSD-25, PYRAHEXYL AND CHLORPROMAZINE.

Authors:  H E HILL; C A HAERTZEN; A B WOLBACH; E J MINER
Journal:  Psychopharmacologia       Date:  1963-05-15

2.  An MMPI factor analytic study of alcoholics, narcotic addicts and criminals.

Authors:  H E HILL; C A HAERTZEN; H DAVIS
Journal:  Q J Stud Alcohol       Date:  1962-09

3.  The effects of chlorpromazine and secobarbital on the reaction times of chronic schizophrenics.

Authors:  R D WYNNE; C KORNETSKY
Journal:  Psychopharmacologia       Date:  1960-06-23

4.  Psychopathology of schizophrenia and depression. I. Effect of amytal and amphetamine sulfate on level and maintenance of attention.

Authors:  P E HUSTON; R SENF
Journal:  Am J Psychiatry       Date:  1952-08       Impact factor: 18.112

Review 5.  Psychological deficit in schizophrenia.

Authors:  D Shakow
Journal:  Behav Sci       Date:  1963-10

6.  Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.

Authors:  R E BELLEVILLE; H F FRASER; H ISBELL; C R LOGAN; A WIKLER
Journal:  AMA Arch Neurol Psychiatry       Date:  1956-11
  6 in total
  1 in total

1.  Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.

Authors:  Miriam Z Mintzer; Ryan K Lanier; Michelle R Lofwall; George E Bigelow; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2010-06-09       Impact factor: 4.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.